Data updated: Mar 10, 2026
NOLVADEX
TAMOXIFEN CITRATE
Approved 1977-12-30
10
Indications
--
Phase 3 Trials
2
Priority Reviews
48
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1977-12-30
- Routes
- ORAL
- Dosage Forms
- TABLET
NOLVADEX Approval History
Loading approval history...
What NOLVADEX Treats
10 FDA approvalsOriginally approved for its first indication in 1977 . Covers 10 distinct patient populations.
- Other (10)
Other
(10 approvals)- • Approved indication (Dec 1977)
- • Approved indication (Dec 1986)
- • Approved indication (Mar 1989)
- • Approved indication (Jun 1990)
- • Approved indication (Apr 1993)
- • Approved indication (Mar 1994)
- • Approved indication (Oct 1998) PriorityLabel Letter
- • Approved indication (Jun 2000) PriorityLabel Letter
- • Approved indication (Mar 2006)Label Letter
- • Approved indication (Mar 2009)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
NOLVADEX FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.